glp 1 analogues mechanism of action Frontiers Discovery of GLP-1–Based Drugs for
Description
Summary The therapeutic scope of GLP-1 receptor agonists extends beyond diabetes to multiple other conditions
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG
TNF- and Poly(I:C) induction of A20 and activation of NF-B signaling are independent of ABCF1 in human airway epithelial cells
10.1136/bmj-2021-066084
The mammalian Target of Rapamycin Complex 1 (mTORC1) pathway is implicated in facilitating cell proliferation and protein synthesis in response to GLP-1 signalling (Sheahan et al
